Penserra Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-300
| Closed | -$16K | – | 1586 |
|
|
2021
Q3 | $16K | Hold |
300
| – | – | ﹤0.01% | 1289 |
|
|
2021
Q2 | $12K | Buy |
300
+10
| +3% | +$400 | ﹤0.01% | 1263 |
|
|
2021
Q1 | $12K | Sell |
290
-10
| -3% | -$414 | ﹤0.01% | 1016 |
|
|
2020
Q4 | $13K | Buy |
300
+182
| +154% | +$7.89K | ﹤0.01% | 902 |
|
|
2020
Q3 | $5K | Buy |
+118
| New | +$5K | ﹤0.01% | 861 |
|